Brachytherapy
Volume 7, Issue 4 , Pages 284-285 , October 2008

Rebuttal to Dr. Moul

References 

  1. Eastham JA, Kattan MW, Reidel E, et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol. 2003;170:2292–2295
  2. Swanson GP, Hussey MA, Tangen CM, et al. Predominant treatment failure in post-prostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794. J Clin Oncol. 2007;25:2225–2229
  3. Stock RG, Ho A, Cesaretti JA, et al. Changing the patterns of failure for high-risk prostate cancer patients by optimizing local control. Int J Radiat Oncol Biol Phys. 2006;66:389–394
  4. Stock RG, Stone NN, Cesaretti JA, et al. Biologically effective dose values for prostate brachytherapy: effects on PSA failure and post-treatment biopsy results. Int J Radiat Oncol Biol Phys. 2006;64:527–533
  5. Stock RG, Cesaretti JA, Stone NN. Disease-specific survival following the brachytherapy management of prostate cancer. Int J Radiat Oncol Biol Phys. 2006;64:810–816
  6. Merrick GS, Butler WM, Wallner KE, et al. Androgen deprivation therapy does not impact cause specific survival or overall survival in high risk prostate cancer managed with brachytherapy and supplemental external beam. Int J Radiat Oncol Biol Phys. 2007;68:34–40

PII: S1538-4721(08)00612-0

doi: 10.1016/j.brachy.2008.08.007

Brachytherapy
Volume 7, Issue 4 , Pages 284-285 , October 2008

Article Tools